SBFM

SBFM

USD

Sunshine Biopharma Inc. Common Stock

$1.510+0.000 (0.000%)

Real-time Price

Healthcare
Drug Manufacturers - Specialty & Generic
United States

Price Chart

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.510

High

$1.570

Low

$1.450

Volume

0.01M

Company Fundamentals

Market Cap

5.6M

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

Trading Stats

Avg Volume

1.43M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.169Current $1.510High $23.2

Related News

AccessWire

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

FORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology

View more
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
AccessWire

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic

View more
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
AccessWire

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic

View more
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
AccessWire

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic

View more
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year